Momenta Pharmaceuticals, Inc.

Momenta is a leader in the analysis, characterization, and design of complex pharmaceutical products. Our scientific foundation is a set of tools and methods that allow us to develop a deep understanding of the links between a compound’s chemical structure, biological function and its manufacturing process. We are applying our innovative technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for autoimmune indications.In 2010, we validated our approach to the development of highly complex molecules by becoming the first company to achieve U.S. regulatory approval of a generic version


Bank Name Momenta Pharmaceuticals, Inc.
Stock Exchange NASDAQ
Symbol MNTA
Sector Healthcare
Industry Biotechnology: Biological Products
Country United States
World Region Amarica
CEO Mr. Craig A. Wheeler
Employees 279
Registered Year 2001